We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

114 hedge funds and large institutions have $510M invested in VanEck Pharmaceutical ETF in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

698% more call options, than puts

Call options by funds: $3.29M | Put options by funds: $412K

300% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 10

33% more funds holding

Funds holding: 86 → 114 (+28)

23% more capital invested

Capital invested by funds: $416M → $510M (+$94.3M)

10.69% more ownership

Funds ownership: 77.28% → 87.97% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

12% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 25

Holders
114
Holders Change
+28
Holders Change %
+32.56%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
40
Increased
22
Reduced
25
Closed
10
Calls
$3.29M
Puts
$412K
Net Calls
+$2.88M
Net Calls Change
-$4.11M

Top Buyers

Rank Fund Capital Flow
1
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$25.4M
2
Bank of America
Bank of America
North Carolina
+$15.9M
3
PCIA
Prime Capital Investment Advisors
Kansas
+$11.2M
4
VAS
Valicenti Advisory Services
New York
+$5.31M
5
AF
Alerus Financial
North Dakota
+$3.5M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$18.4M
2
NI
Noked Israel
Israel
-$9.41M
3
UBS Group
UBS Group
Switzerland
-$7.18M
4
TRCT
Tower Research Capital (TRC)
New York
-$3.48M
5
HF
HRT Financial
New York
-$3.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
MML Investors Services
51
MML Investors Services
Massachusetts
$344K +$26.5K +359 +9%
NFG
52
Nadler Financial Group
Illinois
$342K +$325K +4,405 New
Janney Montgomery Scott
53
Janney Montgomery Scott
Pennsylvania
$341K +$323K +4,385 New
JMPWA
54
JP Morgan Private Wealth Advisors
California
$334K – – –
EDRH
55
Edmond de Rothschild Holding
Switzerland
$330K – – –
IA
56
IFG Advisory
Georgia
$326K +$310K +4,199 New
WSCM
57
Wellington Shields Capital Management
New York
$311K – – –
Neuberger Berman Group
58
Neuberger Berman Group
New York
$288K – – –
JIP
59
Jaffetilchin Investment Partners
Florida
$287K +$273K +3,697 New
CA
60
Continuum Advisory
Idaho
$286K +$271K +3,673 New
WF
61
Warner Financial
Maryland
$282K +$268K +3,633 New
KIA
62
KCM Investment Advisors
California
$266K -$738 -10 -0.3%
BPA
63
Beacon Pointe Advisors
California
$237K – – –
KWM
64
Kingsview Wealth Management
Oregon
$236K – – –
LSPW
65
Lake Street Private Wealth
Illinois
$233K -$165K -2,237 -43%
MIM
66
Miller Investment Management
Pennsylvania
$227K +$216K +2,923 New
Cetera Investment Advisers
67
Cetera Investment Advisers
Illinois
$227K +$215K +2,921 New
CAN
68
Cetera Advisor Networks
California
$210K +$199K +2,696 New
CIBC World Market
69
CIBC World Market
Ontario, Canada
$205K +$195K +2,640 New
NAM
70
NTV Asset Management
West Virginia
$202K +$192K +2,600 New
AP
71
Advisors Preferred
Maryland
$126K +$119K +1,607 New
MA
72
Montag & Associates
Georgia
$107K – – –
Citigroup
73
Citigroup
New York
$102K +$81.7K +1,108 +554%
Rockefeller Capital Management
74
Rockefeller Capital Management
New York
$101K – – –
NSIM
75
North Star Investment Management
Illinois
$87K – – –
1 2
3
4 5

PPH Hedge Fund Activity: Q4 2022 in Review

114 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q4 2022, worth a combined $510M — up 23% from $416M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new PPH positions and 10 closed out — a net gain of 30 holders — while 22 added to existing stakes and 25 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $25.4M. The largest seller was Goldman Sachs, cutting an estimated $18.4M.

  • 114 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q4 2022, up from 86 in Q3 2022.
  • Funds reported $510M of VanEck Pharmaceutical ETF stock for Q4 2022, up 23% quarter-over-quarter.
  • 40 funds opened new VanEck Pharmaceutical ETF positions in Q4 2022 and 10 closed out, a net change of +30 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q4 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $25.4M added.
  • The largest VanEck Pharmaceutical ETF seller in Q4 2022 was Goldman Sachs, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2022.